Lv31
340 积分 2024-01-10 加入
Alpha-Particle Therapy with an Actinium-225 Labeled Bivalent Inhibitor of Prostate-Specific Membrane Antigen is Therapeutically Efficacious in a Mouse Model of Prostate Cancer
56分钟前
已完结
Validation of a New Methodology to Create Oral Drugs beyond the Rule of 5 for Intracellular Tough Targets
10天前
已完结
Imbuing peptide libraries with drug-likeness
10天前
已完结
Validation of a New Methodology to Create Oral Drugs beyond the Rule of 5 for Intracellular Tough Targets
10天前
已完结
Development of Orally Bioavailable Peptides Targeting an Intracellular Protein: From a Hit to a Clinical KRAS Inhibitor
10天前
已完结
Synthetic Approaches to the New Drugs Approved During 2024
21天前
已完结
Radiochemistry and comparative in vitro assessment of PSMA-617 labeled with lead-212 (212Pb), actinium-225 (225Ac), and lutetium-177 (177Lu)
1个月前
已完结
Safety and Efficacy Study of 225Ac-DOTA-IBA in the Treatment of Bone Metastases
3个月前
已完结
Increased Uptake of 68Ga-DOTA-IBA in Sclerosing Epithelioid Fibrosarcoma
3个月前
已关闭
Applications of contemporary tools to measure plasma protein binding of targeted protein degraders
3个月前
已完结
皖公网安备34019202002308
